| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 32 | 2019 | 150 | 9.030 |
Why?
|
| Software | 17 | 2018 | 121 | 6.070 |
Why?
|
| MEDLINE | 19 | 2019 | 26 | 2.930 |
Why?
|
| Periodicals as Topic | 15 | 2017 | 50 | 2.890 |
Why?
|
| Algorithms | 13 | 2018 | 419 | 2.740 |
Why?
|
| Gene Expression Profiling | 21 | 2019 | 439 | 2.680 |
Why?
|
| Genomics | 14 | 2019 | 116 | 2.530 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 17 | 2015 | 190 | 2.450 |
Why?
|
| DNA Methylation | 16 | 2022 | 150 | 2.410 |
Why?
|
| Databases, Genetic | 14 | 2021 | 47 | 2.320 |
Why?
|
| Internet | 12 | 2017 | 121 | 2.210 |
Why?
|
| Information Storage and Retrieval | 13 | 2008 | 31 | 2.080 |
Why?
|
| Aging | 23 | 2022 | 943 | 2.000 |
Why?
|
| Systems Biology | 8 | 2019 | 21 | 1.890 |
Why?
|
| Artificial Intelligence | 6 | 2008 | 43 | 1.510 |
Why?
|
| Publications | 5 | 2018 | 24 | 1.420 |
Why?
|
| Epigenesis, Genetic | 13 | 2022 | 145 | 1.400 |
Why?
|
| Membrane Proteins | 10 | 2023 | 466 | 1.380 |
Why?
|
| Gene Regulatory Networks | 9 | 2022 | 77 | 1.340 |
Why?
|
| Models, Biological | 4 | 2018 | 446 | 1.290 |
Why?
|
| Animals | 70 | 2023 | 9957 | 1.250 |
Why?
|
| Database Management Systems | 8 | 2008 | 12 | 1.240 |
Why?
|
| Humans | 88 | 2023 | 26821 | 1.170 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2019 | 106 | 1.130 |
Why?
|
| Bibliometrics | 5 | 2019 | 19 | 1.120 |
Why?
|
| Gene Expression Regulation | 17 | 2021 | 627 | 1.110 |
Why?
|
| Biomarkers, Tumor | 6 | 2019 | 376 | 1.070 |
Why?
|
| Gene Expression | 7 | 2020 | 406 | 1.070 |
Why?
|
| Brain Neoplasms | 5 | 2019 | 288 | 1.030 |
Why?
|
| Mice | 45 | 2023 | 4406 | 0.990 |
Why?
|
| MicroRNAs | 8 | 2022 | 280 | 0.990 |
Why?
|
| Cell Differentiation | 10 | 2021 | 395 | 0.980 |
Why?
|
| Computers | 3 | 2016 | 29 | 0.970 |
Why?
|
| Natural Language Processing | 7 | 2007 | 16 | 0.970 |
Why?
|
| Signal Transduction | 16 | 2021 | 1344 | 0.950 |
Why?
|
| Glioma | 3 | 2017 | 118 | 0.950 |
Why?
|
| Data Interpretation, Statistical | 2 | 2019 | 56 | 0.930 |
Why?
|
| Lupus Erythematosus, Systemic | 13 | 2022 | 985 | 0.920 |
Why?
|
| Gene Ontology | 4 | 2018 | 12 | 0.910 |
Why?
|
| Databases, Bibliographic | 6 | 2007 | 10 | 0.910 |
Why?
|
| Transcriptome | 11 | 2022 | 199 | 0.860 |
Why?
|
| Research | 4 | 2014 | 88 | 0.860 |
Why?
|
| Sequence Analysis, Protein | 2 | 2018 | 15 | 0.860 |
Why?
|
| Models, Statistical | 2 | 2018 | 118 | 0.820 |
Why?
|
| T-Lymphocytes | 5 | 2022 | 274 | 0.810 |
Why?
|
| Authorship | 6 | 2014 | 13 | 0.800 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2020 | 46 | 0.790 |
Why?
|
| Transcription, Genetic | 9 | 2021 | 400 | 0.790 |
Why?
|
| Biological Clocks | 1 | 2021 | 7 | 0.780 |
Why?
|
| Epigenomics | 6 | 2022 | 29 | 0.780 |
Why?
|
| Antigens, CD | 6 | 2023 | 134 | 0.770 |
Why?
|
| Probability | 2 | 2019 | 75 | 0.750 |
Why?
|
| Pattern Recognition, Automated | 5 | 2008 | 32 | 0.730 |
Why?
|
| Databases, Factual | 5 | 2018 | 250 | 0.720 |
Why?
|
| Cell Proliferation | 11 | 2022 | 766 | 0.710 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2019 | 77 | 0.700 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 4 | 2021 | 47 | 0.700 |
Why?
|
| Microarray Analysis | 6 | 2015 | 59 | 0.690 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2020 | 542 | 0.690 |
Why?
|
| Publication Bias | 1 | 2019 | 11 | 0.690 |
Why?
|
| Male | 43 | 2023 | 12866 | 0.690 |
Why?
|
| Sequence Analysis, DNA | 4 | 2018 | 364 | 0.660 |
Why?
|
| Hippocampus | 6 | 2019 | 186 | 0.660 |
Why?
|
| RNA, Messenger | 8 | 2019 | 646 | 0.660 |
Why?
|
| Mice, Inbred C57BL | 24 | 2022 | 1476 | 0.650 |
Why?
|
| Sequence Analysis, RNA | 3 | 2017 | 57 | 0.640 |
Why?
|
| Metagenomics | 1 | 2019 | 49 | 0.630 |
Why?
|
| RNA | 2 | 2018 | 105 | 0.630 |
Why?
|
| Cytokines | 6 | 2021 | 439 | 0.620 |
Why?
|
| Endothelial Cells | 8 | 2016 | 324 | 0.620 |
Why?
|
| Supervised Machine Learning | 1 | 2018 | 8 | 0.610 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 11 | 0.610 |
Why?
|
| Metadata | 1 | 2017 | 3 | 0.610 |
Why?
|
| Proteins | 2 | 2018 | 244 | 0.600 |
Why?
|
| Data Mining | 1 | 2018 | 15 | 0.600 |
Why?
|
| Carcinogens | 1 | 2018 | 37 | 0.600 |
Why?
|
| Microbiota | 1 | 2019 | 79 | 0.590 |
Why?
|
| Brain | 7 | 2021 | 698 | 0.580 |
Why?
|
| Female | 36 | 2021 | 14452 | 0.560 |
Why?
|
| Data Accuracy | 1 | 2016 | 9 | 0.550 |
Why?
|
| Glioblastoma | 2 | 2019 | 95 | 0.550 |
Why?
|
| Molecular Sequence Annotation | 2 | 2017 | 19 | 0.550 |
Why?
|
| Peer Review, Research | 2 | 2007 | 8 | 0.540 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2021 | 290 | 0.530 |
Why?
|
| Lymphocyte Activation | 2 | 2016 | 204 | 0.530 |
Why?
|
| Transcription Factors | 6 | 2021 | 511 | 0.520 |
Why?
|
| Neutrophils | 5 | 2018 | 177 | 0.510 |
Why?
|
| Databases, Nucleic Acid | 2 | 2013 | 7 | 0.510 |
Why?
|
| Terminology as Topic | 3 | 2004 | 53 | 0.500 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 205 | 0.500 |
Why?
|
| Calcium-Binding Proteins | 2 | 2020 | 60 | 0.480 |
Why?
|
| Rats | 10 | 2018 | 1545 | 0.480 |
Why?
|
| Publishing | 5 | 2016 | 30 | 0.470 |
Why?
|
| Neoplasm Proteins | 4 | 2020 | 122 | 0.470 |
Why?
|
| Information Systems | 2 | 2011 | 7 | 0.460 |
Why?
|
| Sequence Analysis | 2 | 2005 | 14 | 0.460 |
Why?
|
| Inflammation | 7 | 2023 | 601 | 0.460 |
Why?
|
| Endocytosis | 5 | 2023 | 81 | 0.460 |
Why?
|
| Prostatic Neoplasms | 5 | 2023 | 270 | 0.450 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2022 | 100 | 0.450 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 100 | 0.450 |
Why?
|
| Immunity, Innate | 4 | 2021 | 205 | 0.450 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 9 | 0.450 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 35 | 0.450 |
Why?
|
| Genome-Wide Association Study | 7 | 2020 | 236 | 0.450 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 27 | 0.450 |
Why?
|
| Protein Biosynthesis | 3 | 2020 | 106 | 0.440 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2020 | 664 | 0.440 |
Why?
|
| Oxidative Stress | 10 | 2020 | 624 | 0.420 |
Why?
|
| Caloric Restriction | 3 | 2021 | 73 | 0.420 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 151 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2020 | 441 | 0.410 |
Why?
|
| Phenotype | 9 | 2022 | 665 | 0.390 |
Why?
|
| Longevity | 4 | 2021 | 129 | 0.390 |
Why?
|
| Chromatin | 5 | 2022 | 73 | 0.390 |
Why?
|
| Rejuvenation | 3 | 2020 | 26 | 0.390 |
Why?
|
| Automation | 3 | 2017 | 19 | 0.380 |
Why?
|
| Receptor, Notch3 | 2 | 2021 | 15 | 0.380 |
Why?
|
| Neoplasms | 5 | 2023 | 748 | 0.380 |
Why?
|
| Parabiosis | 2 | 2022 | 17 | 0.370 |
Why?
|
| Bronchi | 2 | 2021 | 38 | 0.370 |
Why?
|
| Proteome | 2 | 2008 | 75 | 0.370 |
Why?
|
| Dendritic Cells | 3 | 2020 | 142 | 0.360 |
Why?
|
| Information Dissemination | 2 | 2008 | 35 | 0.360 |
Why?
|
| Middle Aged | 15 | 2021 | 6812 | 0.360 |
Why?
|
| Germ Cells | 2 | 2021 | 16 | 0.350 |
Why?
|
| Cells, Cultured | 12 | 2021 | 970 | 0.350 |
Why?
|
| Sarcopenia | 2 | 2020 | 41 | 0.340 |
Why?
|
| Biomarkers | 6 | 2021 | 733 | 0.340 |
Why?
|
| Nicotinamide Mononucleotide | 2 | 2020 | 23 | 0.340 |
Why?
|
| B-Lymphocytes | 4 | 2019 | 275 | 0.330 |
Why?
|
| Cell Line, Tumor | 9 | 2022 | 1263 | 0.330 |
Why?
|
| Neovascularization, Pathologic | 3 | 2017 | 144 | 0.330 |
Why?
|
| Confidence Intervals | 2 | 2019 | 66 | 0.320 |
Why?
|
| Hypertension | 3 | 2017 | 304 | 0.320 |
Why?
|
| CpG Islands | 4 | 2022 | 24 | 0.320 |
Why?
|
| Congresses as Topic | 3 | 2013 | 32 | 0.320 |
Why?
|
| Takayasu Arteritis | 2 | 2020 | 5 | 0.310 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 747 | 0.310 |
Why?
|
| Adult | 14 | 2021 | 7378 | 0.310 |
Why?
|
| Aged | 12 | 2021 | 5158 | 0.300 |
Why?
|
| Membrane Microdomains | 4 | 2018 | 36 | 0.300 |
Why?
|
| Neovascularization, Physiologic | 4 | 2018 | 123 | 0.300 |
Why?
|
| Mice, Knockout | 10 | 2020 | 782 | 0.300 |
Why?
|
| Genetic Loci | 2 | 2021 | 78 | 0.300 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2007 | 11 | 0.300 |
Why?
|
| Promoter Regions, Genetic | 5 | 2017 | 333 | 0.290 |
Why?
|
| Precursor Cells, T-Lymphoid | 2 | 2019 | 7 | 0.290 |
Why?
|
| Sulfites | 2 | 2018 | 8 | 0.290 |
Why?
|
| Endometriosis | 1 | 2007 | 19 | 0.290 |
Why?
|
| Aorta | 2 | 2019 | 123 | 0.290 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 276 | 0.280 |
Why?
|
| Cellular Senescence | 3 | 2021 | 121 | 0.280 |
Why?
|
| Lung | 4 | 2023 | 349 | 0.280 |
Why?
|
| Optic Neuritis | 2 | 2016 | 11 | 0.270 |
Why?
|
| Mitochondria | 6 | 2021 | 333 | 0.270 |
Why?
|
| Patents as Topic | 1 | 2006 | 5 | 0.270 |
Why?
|
| Muscular Atrophy | 3 | 2020 | 31 | 0.270 |
Why?
|
| Antibodies, Monoclonal | 2 | 2019 | 316 | 0.270 |
Why?
|
| DNA-Binding Proteins | 4 | 2018 | 482 | 0.270 |
Why?
|
| Dermatology | 1 | 2006 | 13 | 0.270 |
Why?
|
| Plant Viruses | 1 | 2006 | 1 | 0.270 |
Why?
|
| Genome, Human | 2 | 2019 | 71 | 0.270 |
Why?
|
| Correspondence as Topic | 1 | 2006 | 2 | 0.270 |
Why?
|
| Computer Communication Networks | 1 | 2006 | 4 | 0.270 |
Why?
|
| Sex Characteristics | 4 | 2020 | 162 | 0.270 |
Why?
|
| Electronic Mail | 1 | 2006 | 10 | 0.260 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 305 | 0.260 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2016 | 45 | 0.260 |
Why?
|
| Mutation | 4 | 2022 | 819 | 0.260 |
Why?
|
| Tetraspanins | 3 | 2023 | 36 | 0.260 |
Why?
|
| Truth Disclosure | 1 | 2005 | 24 | 0.260 |
Why?
|
| Ecology | 1 | 2006 | 47 | 0.260 |
Why?
|
| Data Collection | 1 | 2006 | 101 | 0.260 |
Why?
|
| Interferon Type I | 3 | 2015 | 55 | 0.250 |
Why?
|
| Programming Languages | 2 | 2018 | 6 | 0.250 |
Why?
|
| Kangai-1 Protein | 2 | 2015 | 5 | 0.250 |
Why?
|
| Biodiversity | 1 | 2006 | 99 | 0.250 |
Why?
|
| Adipose Tissue | 2 | 2018 | 179 | 0.250 |
Why?
|
| Abbreviations as Topic | 1 | 2005 | 1 | 0.250 |
Why?
|
| Zebrafish | 3 | 2021 | 95 | 0.250 |
Why?
|
| Intestinal Mucosa | 2 | 2023 | 186 | 0.240 |
Why?
|
| Proteomics | 3 | 2020 | 177 | 0.240 |
Why?
|
| Case-Control Studies | 5 | 2021 | 702 | 0.230 |
Why?
|
| Ovarian Neoplasms | 2 | 2020 | 563 | 0.230 |
Why?
|
| Chromosomes, Human | 2 | 2017 | 31 | 0.230 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2017 | 49 | 0.220 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 65 | 0.220 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 284 | 0.220 |
Why?
|
| Fibroblasts | 3 | 2020 | 152 | 0.220 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 1393 | 0.220 |
Why?
|
| Genetic Variation | 4 | 2019 | 229 | 0.220 |
Why?
|
| Receptors, Interferon | 1 | 2023 | 12 | 0.220 |
Why?
|
| Mice, Transgenic | 7 | 2020 | 487 | 0.220 |
Why?
|
| Age Factors | 4 | 2020 | 716 | 0.220 |
Why?
|
| Sequence Alignment | 2 | 2002 | 110 | 0.210 |
Why?
|
| Meta-Analysis as Topic | 2 | 2014 | 32 | 0.210 |
Why?
|
| Histones | 4 | 2019 | 90 | 0.210 |
Why?
|
| Time Factors | 6 | 2021 | 1563 | 0.210 |
Why?
|
| Spindle Apparatus | 3 | 2020 | 52 | 0.210 |
Why?
|
| Biomedical Research | 2 | 2019 | 93 | 0.210 |
Why?
|
| Insulin | 2 | 2021 | 310 | 0.200 |
Why?
|
| Biology | 3 | 2021 | 13 | 0.200 |
Why?
|
| Hybridization, Genetic | 1 | 2002 | 18 | 0.200 |
Why?
|
| Carotid Arteries | 2 | 2020 | 52 | 0.200 |
Why?
|
| Immunohistochemistry | 4 | 2020 | 453 | 0.200 |
Why?
|
| Repressor Proteins | 2 | 2021 | 114 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2021 | 117 | 0.200 |
Why?
|
| ErbB Receptors | 1 | 2022 | 96 | 0.200 |
Why?
|
| Chromosomes | 1 | 2022 | 59 | 0.200 |
Why?
|
| Cysts | 1 | 2022 | 21 | 0.200 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2022 | 26 | 0.200 |
Why?
|
| Eye Proteins | 2 | 2017 | 197 | 0.200 |
Why?
|
| Caveolin 1 | 2 | 2020 | 43 | 0.200 |
Why?
|
| Heat-Shock Response | 1 | 2021 | 12 | 0.200 |
Why?
|
| Skin | 2 | 2020 | 140 | 0.190 |
Why?
|
| Lysine-tRNA Ligase | 1 | 2021 | 3 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 251 | 0.190 |
Why?
|
| Motor Neurons | 1 | 2022 | 41 | 0.190 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 8 | 0.190 |
Why?
|
| Base Sequence | 4 | 2013 | 573 | 0.190 |
Why?
|
| Neuronal Plasticity | 2 | 2019 | 49 | 0.190 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2020 | 98 | 0.190 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 1924 | 0.190 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2013 | 15 | 0.190 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 262 | 0.190 |
Why?
|
| Caenorhabditis elegans | 1 | 2021 | 58 | 0.190 |
Why?
|
| Goblet Cells | 1 | 2021 | 14 | 0.190 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2021 | 55 | 0.190 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 51 | 0.190 |
Why?
|
| Aminoquinolines | 1 | 2020 | 11 | 0.190 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2020 | 17 | 0.190 |
Why?
|
| Muscle Weakness | 1 | 2020 | 15 | 0.190 |
Why?
|
| Obesity | 2 | 2019 | 648 | 0.180 |
Why?
|
| Blotting, Western | 4 | 2020 | 503 | 0.180 |
Why?
|
| Hearing Loss | 1 | 2021 | 37 | 0.180 |
Why?
|
| Smoke | 1 | 2021 | 36 | 0.180 |
Why?
|
| Benzamides | 1 | 2020 | 32 | 0.180 |
Why?
|
| Meiosis | 1 | 2021 | 56 | 0.180 |
Why?
|
| Lipid Peroxides | 1 | 2020 | 6 | 0.180 |
Why?
|
| Phospholipases A2 | 1 | 2020 | 9 | 0.180 |
Why?
|
| Cytosol | 2 | 2020 | 47 | 0.180 |
Why?
|
| Dietary Supplements | 2 | 2020 | 213 | 0.180 |
Why?
|
| Retinitis | 1 | 2020 | 8 | 0.180 |
Why?
|
| Microvessels | 3 | 2019 | 85 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 58 | 0.180 |
Why?
|
| Chondrosarcoma | 1 | 2020 | 6 | 0.180 |
Why?
|
| Cell Line | 5 | 2022 | 672 | 0.180 |
Why?
|
| Metformin | 1 | 2020 | 32 | 0.180 |
Why?
|
| Re-Epithelialization | 1 | 2020 | 5 | 0.180 |
Why?
|
| Neurons | 3 | 2017 | 275 | 0.180 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 37 | 0.170 |
Why?
|
| Lymphocytes | 1 | 2020 | 83 | 0.170 |
Why?
|
| Cation Transport Proteins | 1 | 2020 | 54 | 0.170 |
Why?
|
| Apoptosis | 4 | 2017 | 739 | 0.170 |
Why?
|
| Myofibroblasts | 1 | 2020 | 22 | 0.170 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 38 | 0.170 |
Why?
|
| X Chromosome Inactivation | 1 | 2019 | 3 | 0.170 |
Why?
|
| Sirolimus | 1 | 2020 | 68 | 0.170 |
Why?
|
| Sirtuin 1 | 1 | 2020 | 39 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2017 | 23 | 0.170 |
Why?
|
| Spinal Cord | 1 | 2022 | 202 | 0.170 |
Why?
|
| Retinal Ganglion Cells | 2 | 2016 | 26 | 0.170 |
Why?
|
| United States | 6 | 2020 | 2031 | 0.170 |
Why?
|
| Cigarette Smoking | 1 | 2021 | 77 | 0.170 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 152 | 0.170 |
Why?
|
| Prostate | 2 | 2019 | 51 | 0.170 |
Why?
|
| Genetic Markers | 2 | 2017 | 92 | 0.170 |
Why?
|
| Quality Control | 2 | 2011 | 20 | 0.170 |
Why?
|
| Child Nutrition Sciences | 1 | 2019 | 3 | 0.170 |
Why?
|
| Visual Acuity | 2 | 2016 | 106 | 0.170 |
Why?
|
| Cell Movement | 5 | 2022 | 352 | 0.170 |
Why?
|
| Transcription Factor 4 | 1 | 2019 | 5 | 0.160 |
Why?
|
| Eicosanoids | 1 | 2019 | 10 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 121 | 0.160 |
Why?
|
| Embryo, Nonmammalian | 2 | 2017 | 25 | 0.160 |
Why?
|
| History, 21st Century | 1 | 2019 | 49 | 0.160 |
Why?
|
| Plasma Cells | 1 | 2019 | 21 | 0.160 |
Why?
|
| Rats, Inbred F344 | 3 | 2014 | 167 | 0.160 |
Why?
|
| Microtubules | 2 | 2017 | 89 | 0.160 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 55 | 0.160 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2019 | 30 | 0.160 |
Why?
|
| HeLa Cells | 3 | 2017 | 206 | 0.160 |
Why?
|
| Dasatinib | 2 | 2016 | 16 | 0.160 |
Why?
|
| Up-Regulation | 5 | 2020 | 240 | 0.160 |
Why?
|
| Quercetin | 2 | 2016 | 14 | 0.160 |
Why?
|
| Alzheimer Disease | 2 | 2018 | 210 | 0.160 |
Why?
|
| DNA Damage | 1 | 2019 | 149 | 0.160 |
Why?
|
| Immunologic Memory | 1 | 2019 | 58 | 0.160 |
Why?
|
| Interferon-alpha | 1 | 2018 | 50 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2016 | 119 | 0.150 |
Why?
|
| Argonaute Proteins | 1 | 2018 | 1 | 0.150 |
Why?
|
| Intercellular Junctions | 1 | 2018 | 8 | 0.150 |
Why?
|
| Liver | 2 | 2018 | 415 | 0.150 |
Why?
|
| Methyltransferases | 1 | 2018 | 12 | 0.150 |
Why?
|
| RNA Stability | 1 | 2018 | 27 | 0.150 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2016 | 114 | 0.150 |
Why?
|
| NF-kappa B | 3 | 2014 | 187 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 340 | 0.150 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 71 | 0.150 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2017 | 4 | 0.150 |
Why?
|
| Sensitivity and Specificity | 3 | 2005 | 508 | 0.150 |
Why?
|
| Eukaryota | 1 | 2018 | 19 | 0.150 |
Why?
|
| HEK293 Cells | 3 | 2013 | 171 | 0.150 |
Why?
|
| Synaptic Vesicles | 1 | 2017 | 17 | 0.150 |
Why?
|
| Pediatrics | 1 | 2019 | 87 | 0.150 |
Why?
|
| Interferons | 3 | 2023 | 68 | 0.150 |
Why?
|
| Organ Specificity | 1 | 2018 | 81 | 0.150 |
Why?
|
| Reference Standards | 1 | 2017 | 54 | 0.150 |
Why?
|
| Cognitive Dysfunction | 2 | 2019 | 259 | 0.150 |
Why?
|
| Bayes Theorem | 1 | 2018 | 90 | 0.150 |
Why?
|
| Neurogenesis | 1 | 2017 | 21 | 0.150 |
Why?
|
| Aurora Kinase B | 1 | 2017 | 12 | 0.150 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 72 | 0.150 |
Why?
|
| DNA | 2 | 2017 | 365 | 0.150 |
Why?
|
| Plants | 1 | 2018 | 64 | 0.150 |
Why?
|
| Seizures | 1 | 2017 | 46 | 0.150 |
Why?
|
| Pancreatic Polypeptide-Secreting Cells | 1 | 2017 | 1 | 0.150 |
Why?
|
| Vascular Diseases | 1 | 2018 | 67 | 0.150 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2015 | 27 | 0.150 |
Why?
|
| Extracellular Traps | 1 | 2017 | 9 | 0.150 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2017 | 30 | 0.150 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 200 | 0.150 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 42 | 0.150 |
Why?
|
| Tobacco Products | 1 | 2021 | 190 | 0.140 |
Why?
|
| DNA Replication Timing | 1 | 2017 | 3 | 0.140 |
Why?
|
| Duodenum | 1 | 2017 | 15 | 0.140 |
Why?
|
| Journal Impact Factor | 1 | 2017 | 8 | 0.140 |
Why?
|
| Liraglutide | 1 | 2017 | 6 | 0.140 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 56 | 0.140 |
Why?
|
| Neuralgia | 1 | 2017 | 18 | 0.140 |
Why?
|
| Complement System Proteins | 1 | 2017 | 24 | 0.140 |
Why?
|
| Scleroderma, Diffuse | 1 | 2016 | 2 | 0.140 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2016 | 1 | 0.140 |
Why?
|
| Pancreas | 1 | 2017 | 58 | 0.140 |
Why?
|
| Machine Learning | 1 | 2017 | 78 | 0.140 |
Why?
|
| Histone Deacetylases | 1 | 2016 | 22 | 0.140 |
Why?
|
| Retina | 1 | 2020 | 421 | 0.140 |
Why?
|
| Neocortex | 1 | 2016 | 7 | 0.140 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 88 | 0.140 |
Why?
|
| Microvascular Rarefaction | 1 | 2016 | 13 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 309 | 0.140 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 105 | 0.140 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 3 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 139 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2017 | 198 | 0.130 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2016 | 34 | 0.130 |
Why?
|
| Markov Chains | 2 | 2006 | 16 | 0.130 |
Why?
|
| Cerebral Hemorrhage | 1 | 2017 | 90 | 0.130 |
Why?
|
| Epithelial Cells | 3 | 2023 | 240 | 0.130 |
Why?
|
| Myelin Sheath | 1 | 2016 | 25 | 0.130 |
Why?
|
| Aniline Compounds | 1 | 2016 | 21 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2017 | 104 | 0.130 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 40 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 111 | 0.130 |
Why?
|
| Major Histocompatibility Complex | 1 | 2016 | 27 | 0.130 |
Why?
|
| Histone Demethylases | 1 | 2016 | 9 | 0.130 |
Why?
|
| Rhombencephalon | 1 | 2015 | 3 | 0.130 |
Why?
|
| Binding Sites | 2 | 2013 | 338 | 0.130 |
Why?
|
| Antibodies, Antinuclear | 1 | 2017 | 181 | 0.130 |
Why?
|
| Th17 Cells | 1 | 2016 | 32 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2015 | 37 | 0.130 |
Why?
|
| Computer Simulation | 2 | 2008 | 221 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 128 | 0.130 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2015 | 15 | 0.130 |
Why?
|
| Chronic Pain | 1 | 2017 | 59 | 0.130 |
Why?
|
| Factor VIII | 1 | 2015 | 19 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 67 | 0.130 |
Why?
|
| Prognosis | 2 | 2019 | 759 | 0.130 |
Why?
|
| Protein C | 1 | 2015 | 38 | 0.130 |
Why?
|
| Brachial Artery | 1 | 2015 | 36 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2016 | 68 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2015 | 132 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2015 | 4 | 0.130 |
Why?
|
| Bacteria | 1 | 2018 | 263 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 180 | 0.130 |
Why?
|
| Ribosomal Proteins | 1 | 2015 | 20 | 0.130 |
Why?
|
| Neuroendocrine Tumors | 1 | 2015 | 29 | 0.120 |
Why?
|
| Interleukin-7 | 1 | 2015 | 10 | 0.120 |
Why?
|
| Interleukin-18 | 1 | 2015 | 16 | 0.120 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 43 | 0.120 |
Why?
|
| African Americans | 1 | 2017 | 350 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2015 | 79 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 109 | 0.120 |
Why?
|
| Lymphopoiesis | 1 | 2015 | 22 | 0.120 |
Why?
|
| Disease Progression | 4 | 2019 | 450 | 0.120 |
Why?
|
| Sjogren's Syndrome | 2 | 2019 | 256 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2016 | 165 | 0.120 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2015 | 14 | 0.120 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 30 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2014 | 4 | 0.120 |
Why?
|
| Ribosomes | 1 | 2015 | 31 | 0.120 |
Why?
|
| Lymphatic System | 1 | 2014 | 11 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 64 | 0.120 |
Why?
|
| Down-Regulation | 4 | 2018 | 197 | 0.120 |
Why?
|
| Mitosis | 2 | 2020 | 109 | 0.120 |
Why?
|
| Fibrosis | 1 | 2015 | 115 | 0.120 |
Why?
|
| Haplotypes | 2 | 2013 | 279 | 0.120 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2014 | 31 | 0.120 |
Why?
|
| Osteoporosis | 1 | 2015 | 63 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 133 | 0.120 |
Why?
|
| Hyaluronan Receptors | 1 | 2014 | 29 | 0.120 |
Why?
|
| ADAM Proteins | 1 | 2015 | 102 | 0.120 |
Why?
|
| Stilbenes | 1 | 2015 | 90 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2005 | 31 | 0.110 |
Why?
|
| Awards and Prizes | 1 | 2013 | 9 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2015 | 189 | 0.110 |
Why?
|
| Scleroderma, Systemic | 1 | 2013 | 29 | 0.110 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 104 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 322 | 0.110 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 132 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2013 | 37 | 0.110 |
Why?
|
| PubMed | 3 | 2010 | 8 | 0.110 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 10 | 0.110 |
Why?
|
| Interleukin-2 | 1 | 2013 | 33 | 0.110 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2013 | 14 | 0.110 |
Why?
|
| Ferrocyanides | 1 | 2013 | 2 | 0.110 |
Why?
|
| Nucleic Acid Conformation | 1 | 2013 | 90 | 0.110 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 55 | 0.110 |
Why?
|
| Coloring Agents | 1 | 2013 | 33 | 0.110 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 132 | 0.100 |
Why?
|
| Integrins | 2 | 2022 | 27 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 441 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2014 | 181 | 0.100 |
Why?
|
| Audiovisual Aids | 1 | 2012 | 13 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2012 | 71 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2013 | 441 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 3 | 2017 | 310 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 3 | 2018 | 64 | 0.100 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2011 | 18 | 0.100 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2015 | 216 | 0.100 |
Why?
|
| Sample Size | 1 | 2011 | 17 | 0.100 |
Why?
|
| Muscle, Skeletal | 3 | 2020 | 578 | 0.100 |
Why?
|
| Color | 1 | 2011 | 22 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 346 | 0.100 |
Why?
|
| Androgens | 1 | 2011 | 47 | 0.090 |
Why?
|
| Cognition | 1 | 2014 | 294 | 0.090 |
Why?
|
| Medicine | 1 | 2011 | 22 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 507 | 0.090 |
Why?
|
| Lipoproteins | 1 | 2011 | 95 | 0.090 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2010 | 16 | 0.090 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2010 | 17 | 0.090 |
Why?
|
| Lysosomes | 2 | 2022 | 54 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 245 | 0.090 |
Why?
|
| Risk Factors | 4 | 2019 | 2006 | 0.090 |
Why?
|
| Genes | 1 | 2009 | 35 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2020 | 110 | 0.080 |
Why?
|
| Actins | 2 | 2020 | 93 | 0.080 |
Why?
|
| Spleen | 2 | 2020 | 109 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2008 | 34 | 0.080 |
Why?
|
| Vocabulary, Controlled | 2 | 2007 | 2 | 0.080 |
Why?
|
| Young Adult | 4 | 2017 | 2578 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 801 | 0.080 |
Why?
|
| Semantics | 2 | 2007 | 11 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 194 | 0.080 |
Why?
|
| Medical Subject Headings | 1 | 2007 | 3 | 0.080 |
Why?
|
| Eye | 1 | 2008 | 35 | 0.080 |
Why?
|
| Zebrafish Proteins | 1 | 2008 | 19 | 0.080 |
Why?
|
| Cell Cycle | 2 | 2019 | 155 | 0.070 |
Why?
|
| Autoantibodies | 3 | 2017 | 466 | 0.070 |
Why?
|
| Transfection | 3 | 2014 | 312 | 0.070 |
Why?
|
| Research Personnel | 1 | 2007 | 34 | 0.070 |
Why?
|
| Methylation | 2 | 2018 | 21 | 0.070 |
Why?
|
| Alleles | 2 | 2021 | 347 | 0.070 |
Why?
|
| Informatics | 1 | 2007 | 2 | 0.070 |
Why?
|
| Peer Review | 1 | 2007 | 14 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2007 | 114 | 0.070 |
Why?
|
| Mice, Nude | 2 | 2019 | 313 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2020 | 282 | 0.070 |
Why?
|
| Angiotensin II | 2 | 2017 | 54 | 0.070 |
Why?
|
| RNA Interference | 2 | 2017 | 135 | 0.070 |
Why?
|
| Th1 Cells | 2 | 2016 | 35 | 0.070 |
Why?
|
| Forecasting | 1 | 2006 | 71 | 0.070 |
Why?
|
| Models, Animal | 2 | 2017 | 129 | 0.070 |
Why?
|
| Isoproterenol | 1 | 2006 | 23 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2006 | 37 | 0.070 |
Why?
|
| Documentation | 2 | 2004 | 24 | 0.070 |
Why?
|
| Adolescent | 3 | 2019 | 2954 | 0.070 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 110 | 0.070 |
Why?
|
| Melatonin | 1 | 2006 | 23 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2015 | 859 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2017 | 545 | 0.060 |
Why?
|
| Endonucleases | 2 | 2016 | 16 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2006 | 77 | 0.060 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2005 | 2 | 0.060 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2016 | 50 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 18 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2006 | 57 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 980 | 0.060 |
Why?
|
| Cytoskeleton | 2 | 2015 | 40 | 0.060 |
Why?
|
| Adipocytes | 2 | 2016 | 53 | 0.060 |
Why?
|
| Organizations | 1 | 2004 | 4 | 0.060 |
Why?
|
| Blood-Brain Barrier | 2 | 2016 | 82 | 0.060 |
Why?
|
| Geography | 1 | 2004 | 47 | 0.060 |
Why?
|
| Crosses, Genetic | 2 | 2014 | 36 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2016 | 123 | 0.060 |
Why?
|
| Rats, Inbred BN | 2 | 2014 | 70 | 0.060 |
Why?
|
| Research Design | 1 | 2005 | 174 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 279 | 0.060 |
Why?
|
| Maze Learning | 2 | 2014 | 78 | 0.060 |
Why?
|
| Computing Methodologies | 1 | 2004 | 2 | 0.060 |
Why?
|
| Hypermedia | 1 | 2004 | 2 | 0.060 |
Why?
|
| Genome | 2 | 2017 | 53 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 143 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 253 | 0.060 |
Why?
|
| Protein Binding | 2 | 2017 | 631 | 0.050 |
Why?
|
| Clathrin | 1 | 2023 | 19 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2023 | 33 | 0.050 |
Why?
|
| Genotype | 2 | 2016 | 441 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2016 | 176 | 0.050 |
Why?
|
| Papio | 1 | 2023 | 78 | 0.050 |
Why?
|
| Protein Transport | 2 | 2014 | 152 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2006 | 917 | 0.050 |
Why?
|
| Xenopus | 1 | 2022 | 28 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2022 | 47 | 0.050 |
Why?
|
| Computer Graphics | 1 | 2002 | 9 | 0.050 |
Why?
|
| Receptors, Growth Factor | 1 | 2022 | 6 | 0.050 |
Why?
|
| Genome, Fungal | 1 | 2002 | 6 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2002 | 9 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2002 | 30 | 0.050 |
Why?
|
| Yeasts | 1 | 2002 | 6 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2022 | 40 | 0.050 |
Why?
|
| Benzenesulfonates | 1 | 2022 | 18 | 0.050 |
Why?
|
| Imines | 1 | 2022 | 21 | 0.050 |
Why?
|
| Neuromuscular Junction | 1 | 2022 | 21 | 0.050 |
Why?
|
| Air | 1 | 2021 | 22 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2021 | 23 | 0.050 |
Why?
|
| Indoleacetic Acids | 1 | 2021 | 7 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2022 | 110 | 0.050 |
Why?
|
| Cilia | 1 | 2022 | 41 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 34 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 143 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2021 | 52 | 0.050 |
Why?
|
| Artifacts | 1 | 2002 | 50 | 0.050 |
Why?
|
| Cell Death | 1 | 2021 | 110 | 0.050 |
Why?
|
| Melanoma | 1 | 2023 | 140 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 29 | 0.050 |
Why?
|
| Fertility | 1 | 2021 | 58 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 324 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 184 | 0.050 |
Why?
|
| Uncoupling Protein 1 | 1 | 2020 | 13 | 0.050 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2020 | 15 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 34 | 0.050 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2020 | 4 | 0.050 |
Why?
|
| Mitochondria, Muscle | 1 | 2020 | 39 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2017 | 2262 | 0.050 |
Why?
|
| Intravitreal Injections | 1 | 2020 | 33 | 0.050 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2020 | 12 | 0.050 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 23 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 100 | 0.040 |
Why?
|
| Interferon Regulatory Factors | 1 | 2020 | 58 | 0.040 |
Why?
|
| Mitochondrial Membranes | 1 | 2020 | 20 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2020 | 44 | 0.040 |
Why?
|
| Centrosome | 1 | 2020 | 10 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2020 | 262 | 0.040 |
Why?
|
| Granulation Tissue | 1 | 2020 | 7 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2020 | 39 | 0.040 |
Why?
|
| Endothelium | 1 | 2020 | 28 | 0.040 |
Why?
|
| Carotid Artery Injuries | 1 | 2020 | 12 | 0.040 |
Why?
|
| Kidney | 1 | 2022 | 275 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 93 | 0.040 |
Why?
|
| Glycolysis | 1 | 2020 | 82 | 0.040 |
Why?
|
| Salmonella typhimurium | 1 | 2020 | 68 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Histone Deacetylase 2 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 50 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 70 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 139 | 0.040 |
Why?
|
| Chickens | 1 | 2019 | 59 | 0.040 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2019 | 15 | 0.040 |
Why?
|
| Smokers | 1 | 2021 | 124 | 0.040 |
Why?
|
| Electroretinography | 1 | 2020 | 173 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2020 | 77 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2019 | 43 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 108 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 186 | 0.040 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 1 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 21 | 0.040 |
Why?
|
| Plagiarism | 2 | 2010 | 2 | 0.040 |
Why?
|
| Wound Healing | 1 | 2020 | 113 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2019 | 23 | 0.040 |
Why?
|
| Web Browser | 1 | 2019 | 4 | 0.040 |
Why?
|
| Collagen | 1 | 2020 | 147 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 278 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 110 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2019 | 53 | 0.040 |
Why?
|
| Antigens | 1 | 2019 | 66 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 46 | 0.040 |
Why?
|
| Prostatectomy | 1 | 2019 | 83 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 225 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2019 | 91 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2019 | 73 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2019 | 69 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2019 | 558 | 0.040 |
Why?
|
| Monocytes | 1 | 2019 | 132 | 0.040 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2018 | 6 | 0.040 |
Why?
|
| Cytochalasin D | 1 | 2018 | 9 | 0.040 |
Why?
|
| Actin Cytoskeleton | 1 | 2018 | 23 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 89 | 0.040 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2017 | 3 | 0.040 |
Why?
|
| Oklahoma | 1 | 2021 | 973 | 0.040 |
Why?
|
| CD11a Antigen | 1 | 2017 | 2 | 0.040 |
Why?
|
| Receptors, KIR | 1 | 2017 | 3 | 0.040 |
Why?
|
| CD4 Antigens | 1 | 2017 | 18 | 0.040 |
Why?
|
| CD28 Antigens | 1 | 2017 | 11 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 472 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2017 | 58 | 0.040 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2017 | 27 | 0.040 |
Why?
|
| Anaphase | 1 | 2017 | 29 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2017 | 27 | 0.040 |
Why?
|
| Risk | 1 | 2017 | 133 | 0.040 |
Why?
|
| Cytokine TWEAK | 1 | 2017 | 2 | 0.040 |
Why?
|
| Angiostatins | 1 | 2017 | 2 | 0.040 |
Why?
|
| Lipocalin-2 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2017 | 66 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2017 | 11 | 0.040 |
Why?
|
| Tumor Necrosis Factors | 1 | 2017 | 14 | 0.040 |
Why?
|
| Posterior Horn Cells | 1 | 2017 | 10 | 0.040 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2017 | 9 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2017 | 20 | 0.040 |
Why?
|
| Ferritins | 1 | 2017 | 23 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 504 | 0.040 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2017 | 31 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 108 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2017 | 31 | 0.040 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2017 | 42 | 0.040 |
Why?
|
| Paralysis | 1 | 2016 | 9 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2017 | 37 | 0.040 |
Why?
|
| Follistatin-Related Proteins | 1 | 2016 | 1 | 0.040 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2016 | 2 | 0.040 |
Why?
|
| Nectins | 1 | 2016 | 2 | 0.040 |
Why?
|
| Food | 1 | 2017 | 31 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 43 | 0.040 |
Why?
|
| Low Back Pain | 1 | 2017 | 28 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2016 | 29 | 0.030 |
Why?
|
| Optic Nerve | 1 | 2016 | 28 | 0.030 |
Why?
|
| Macular Degeneration | 1 | 2017 | 79 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 446 | 0.030 |
Why?
|
| Methionine | 1 | 2016 | 37 | 0.030 |
Why?
|
| Gait | 1 | 2017 | 58 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2017 | 72 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 9 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 30 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 129 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 2016 | 20 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 131 | 0.030 |
Why?
|
| Cell-Matrix Junctions | 1 | 2015 | 1 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 20 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 28 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 266 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 388 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2015 | 10 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 2 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Ephrins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Turkey | 1 | 2015 | 9 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2016 | 115 | 0.030 |
Why?
|
| Platelet Activation | 1 | 2015 | 54 | 0.030 |
Why?
|
| Intervertebral Disc | 1 | 2015 | 5 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 14 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2015 | 10 | 0.030 |
Why?
|
| North America | 1 | 2015 | 39 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2015 | 17 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 29 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2015 | 50 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2015 | 34 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 58 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 213 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2016 | 80 | 0.030 |
Why?
|
| Regeneration | 1 | 2015 | 76 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2014 | 17 | 0.030 |
Why?
|
| Lymphedema | 1 | 2014 | 13 | 0.030 |
Why?
|
| Gangliosides | 1 | 2014 | 3 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 61 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 231 | 0.030 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 55 | 0.030 |
Why?
|
| Dentate Gyrus | 1 | 2014 | 9 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2014 | 7 | 0.030 |
Why?
|
| Pericytes | 1 | 2014 | 17 | 0.030 |
Why?
|
| ADAMTS13 Protein | 1 | 2015 | 126 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 131 | 0.030 |
Why?
|
| Stem Cells | 1 | 2015 | 113 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 160 | 0.030 |
Why?
|
| Plasmids | 1 | 2014 | 121 | 0.030 |
Why?
|
| Hand Strength | 1 | 2014 | 33 | 0.030 |
Why?
|
| Memory | 1 | 2014 | 71 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 444 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 168 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2014 | 95 | 0.030 |
Why?
|
| Recurrence | 1 | 2015 | 315 | 0.030 |
Why?
|
| Indoles | 1 | 2014 | 97 | 0.030 |
Why?
|
| Heart | 1 | 2015 | 219 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 354 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2015 | 351 | 0.030 |
Why?
|
| Macrophages | 1 | 2016 | 274 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 58 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 130 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2013 | 6 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2013 | 6 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 152 | 0.030 |
Why?
|
| Child | 1 | 2019 | 2145 | 0.030 |
Why?
|
| Half-Life | 1 | 2012 | 32 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2019 | 2427 | 0.030 |
Why?
|
| Protein Stability | 1 | 2012 | 42 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 211 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 131 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2015 | 1216 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 93 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2011 | 27 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 80 | 0.020 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2011 | 6 | 0.020 |
Why?
|
| Cytosine | 1 | 2011 | 6 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 13 | 0.020 |
Why?
|
| Receptors, Calcitriol | 1 | 2010 | 6 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2010 | 9 | 0.020 |
Why?
|
| Retinoid X Receptors | 1 | 2010 | 24 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 54 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 40 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2010 | 9 | 0.020 |
Why?
|
| Search Engine | 1 | 2010 | 7 | 0.020 |
Why?
|
| Estradiol | 1 | 2010 | 174 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 148 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2009 | 5 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 142 | 0.020 |
Why?
|
| Kinetochores | 1 | 2009 | 41 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 394 | 0.020 |
Why?
|
| Centromere | 1 | 2009 | 38 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2011 | 293 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 182 | 0.020 |
Why?
|
| Axin Protein | 1 | 2008 | 3 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 33 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2007 | 22 | 0.020 |
Why?
|
| Software Design | 1 | 2007 | 7 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2007 | 38 | 0.020 |
Why?
|
| Phylogeny | 1 | 2008 | 461 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2005 | 21 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2005 | 14 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2005 | 32 | 0.020 |
Why?
|
| Luciferases | 1 | 2005 | 49 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 205 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2002 | 68 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 163 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 1036 | 0.010 |
Why?
|